Improving Standard Therapies

Dr. Brad Nelson (2003 and 2004 Research Grants)

Dr. Brad Nelson’s research hopes to improve popular prostate cancer treatments like hormone therapy and radiation. In March 2007, he published a study that showed for the first time that, in addition to fighting cancer themselves, these therapies also stimulate the body’s own immune system to fight tumours.

Dr. Nelson identified 21 specific antigens that are released by prostate tumours and attacked by the immune system. He is now using these antigens to develop a drug that can improve the immune-friendly effects of radiation and hormone therapy. Ultimately, this drug – which would be given to men before treatment - could be a cost effective way of making therapy more effective and help men live longer.




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Landmark study links tumour evolution to prostate cancer severity

Toronto (April 19, 2018) – Findings from Canadian Prostate Cancer Genome Network (CPC-GENE) researchers and their collaborators, published today in Cell, show that the aggressiveness of an individual prostate cancer can be accurately assessed by looking at how that tumour has evolved.
More

Can exercise help slow prostate cancer growth?

Toronto, March 12, 2018 – Funded by Prostate Cancer Canada (PCC), Dr.
More

Prostate Cancer Canada’s Rock the Road Raffle sells out for 5th consecutive year

February 23, 2018 – TORONTO, ON – For the fifth year and counting, Prostate Cancer Canada’s (PCC) Rock the Road Raffle brought together Ontarians from all walks of life to both support an important cause and gain a chance to win a one-of-a-kind dream car.
More


Click here for news archive